BlackRock »

Catalyst Pharmaceutical Partners shares owned by BlackRock

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by BlackRock

Quarter filed Position value Share count Share price at filing
2025-09-30 $359M 18M 19.70
2025-06-30 $410M 19M 21.70
2025-03-31 $456M 19M 24.25
2024-12-31 $405M 19M 20.87
2024-09-30 $378M 19M 19.88

More positions owned by BlackRock

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)
Netflix (NFLX)

View all positions for BlackRock

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners